Author Affiliations: Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (Dr Prasad); Department of Medicine, Northwestern University, Chicago, Illinois (Dr Rho); and Department of Medicine, University of Chicago, Chicago (Dr Cifu).
Based on the pathophysiologic characteristics of venous thromboembolism (VTE), the inferior vena cava filter (IVC) should work. Placed between the proximal vessels of the lower extremities—the main source of venous emboli1-3—and the right side of the heart, the IVC filter should capture a blood clot before it reaches the pulmonary circulation and should improve outcomes. This theory, however, has never been validated by empirical studies. This may seem surprising for a device so well established in medical practice. The history of the IVC filter provides valuable insight into the shortcomings of medical device approval in the United States.
Prasad V, Rho J, Cifu A. The Inferior Vena Cava Filter: How Could a Medical Device Be So Well Accepted Without Any Evidence of Efficacy? JAMA Intern Med. 2013;173(7):493–495. doi:10.1001/jamainternmed.2013.2725
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: